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Abstract. The Notch gene encodes a transmembrane
receptor that gave the name to the evolutionary highly
conserved Notch signaling cascade. It plays a pivotal
role in the regulation of many fundamental cellular
processes such as proliferation, stem cell maintenance
and differentiation during embryonic and adult devel-
opment. After specific ligand binding, the intracellu-
lar part of the Notch receptor is cleaved off and
translocates to the nucleus, where it binds to the
transcription factorRBP-J. In the absence of activated
Notch, RBP-J represses Notch target genes by re-
cruiting a corepressor complex. Here, we review
Notch signaling with a focus on gene regulatory
events at Notch target genes. This is of utmost
importance to understand Notch signaling since
certain RBP-J associated cofactors and particular
epigenetic marks determine the specificity of Notch
target gene expression in different cell types. We
subsequently summarize the current knowledge about
Notch target genes and the physiological significance
of Notch signaling in development and cancer.
Keywords. Notch signaling, transcription, recombination signal sequence-binding protein Jkappa (RBP-Jk/
CSL), chromatin and epigenetic regulation, leukemia.
Introduction
TheNotch genewas discovered almost 90 years ago by
Morgan and colleagues who observed that partial loss
of function results in notches at the wing margin in
flies (Drosophila melanogaster) [1]. Decades later in
loss of function experiments, Notch was found to
cause a “neurogenic” phenotype, where cells destined
to becomeepidermis switch fate and give rise to neural
tissue, reviewed in [2, 3]. In the early eighties, the
Notch gene was found to encode a 300kDa single-pass
transmembrane receptor. The extracellular domain of
the Notch receptor contains 36 epidermal growth
factor (EGF)-like repeats essential for ligand binding.
The intracellular domain is involved in cellular signal-
ing and contains multiple conserved protein domains.
Subsequently, Notch-like molecules have been iden-
tified from C. elegans (LIN-12) to humans, playing
important, and apparently conserved, functional roles
in development. In mammals, four Notch receptors
(Notch 1–4) and five transmembrane ligands (Jag-
ged1, Jagged2, Delta-like1, Delta-like3, and Delta-
like4) are described so far. Although Notch was
originally classified as a neurogenic gene even the first
characterization ofDrosophila embryos made it clear
that Notch signals are highly pleiotropic, thereby
affecting many tissues.* Corresponding author.
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The Notch signaling cascade appears remarkably
simple with apparently no second messengers in-
volved. However, the role of Notch signaling and the
activation of downstream genes in a given tissue
remain often complex and unpredictable. Here, we
review in depth what is known so far about transcrip-
tional regulation mediated by Notch. Subsequently,
we summarize the current knowledge about Notch
target genes and, in a broader context, the relevance of
Notch signaling in cell differentiation and cancer.
Molecular mechanism of transcriptional regulation at
Notch target genes
The Notch signaling cascade
Notch signaling is activated upon cell-to-cell contact
as a result of interactions between Notch receptors
and their ligands (Delta or Jagged). At the molecular
level, triggering of Notch receptor by ligand binding
promotes two proteolytic cleavage events at theNotch
receptor (Fig. 1). The first cleavage is catalyzed by the
ADAM-family of metalloproteases, whereas the sec-
ond cleavage is mediated by g-secretase, an enzyme
complex that contains presenilin, nicastrin, PEN2 and
APH1, reviewed in [4]. The second cleavage releases
the Notch intracellular domain (NICD), which then
translocates to the nucleus and acts as a transcriptional
coactivator. NICD cannot bind directly to DNA but
heterodimerizeswith theDNAbinding proteinRBP-J
(recombination signal sequence-binding protein Jk,
also called CSL, CBF1, Su(H) and LAG-1) and
activates transcription of genes containing RBP-J
binding sites.
Interestingly, RBP-J was originally identified as a
repressor of transcription by Vales and colleagues [5].
When studying the promoter region of the adenovirus
pIX gene, a 10bp repressive element was character-
ized and it was shown that RBP-J is the factor that
binds to this element. Subsequently, the RBP-J bind-
ing site was placed in reporter assays next to other
transcriptional activators Gal4-VP16 or SP1, and it
was shown that RBP-J could interfere with transcrip-
tional activation.Other investigators also demonstrat-
ed the RBP-J repressive activity by placing multiple
RBP-J binding sites at a TK-promoter element [6].
The RBP-J mediated repression could either be
relieved by addition of the viral activator EBNA2
(see also below section on Notch in cancer, Epstein-
Barr virus) or by the fusion of RBP-J to VP16
activation domain. The RBP-J activator/repressor
paradox was resolved with the realization that repres-
sion and activation via RBP-J involves the recruit-
ment of distinct protein complexes, which influence
transcription of target genes in a positive or negative
fashion. In the absence of ligand, hence without
nuclear NICD, RBP-J represses Notch target genes
through the recruitment of corepressor complexes.
NICD binding to RBP-J is crucial for the switch from
repressed to activated state. NICD first displaces
corepressors from RBP-J, resulting in derepression of
promoters containing RBP-J binding sites and sub-
sequently recruits a coactivator complex to activate
transcription of Notch target genes.
Notch target genes
Although signals mediated through Notch receptors
have diverse outcomes, only a fairly limited set of
Notch target genes have been identified in various
cellular and developmental contexts. The hairy/en-
hancer of split (Hes) genes are highly conserved
proteins that are regulated by Notch in multiple cell
types, reviewed in [7, 8]. Hairy/Enhancer of split
family genes were first described as neurogenic genes
in Drosophila (like Notch, Deltex and Mastermind),
since embryos lacking the function of these genes
showed an increased number of neuroblasts at the
expense of epidermal precursors, reviewed in [2, 9].
Several lines of evidence have suggested that these
genes are indeed direct Notch target genes: a) The
promoters of Hes1, Hes5 and Hes7 as well as Hey1,
Hey2 and HeyL (subfamily of Hes, related with
YRPW motif) can be activated by a constitutive
active form of Notch1 [10–12], reviewed in [7];
constitutive active Notch describes a mutant of
Notch that is continuously proteolytically processed
andmigrating to the nucleus, b) endogenousHey1 and
Hey2 show an upregulation by NICD in several
different cell lines [13], c) in co-culture experiments
with Notch-ligand expressing cells, that achieve a
more physiological level of Notch signaling, these
genes are upregulated as well [13–15]; these experi-
ments were also performed in the presence of cyclo-
hexamide, an inhibitor of protein synthesis, to exclude
secondary effects, d) k-secretase inhibitor DAPT,
which prevents cleavage of Notch, was added to T-
cell leukemia cell lines which show constitutive-active
Notch signaling; subsequent microarray analysis
identified again members of this transcription factor
family as direct Notch target genes [16]. Therefore, in
mammals, the best-described Notch target genes are
indeed the transcription factors Hes1, Hes5 and Hey1
[8, 17]. Hes and Hey proteins are helix-loop-helix
transcription factors that function as transcriptional
repressors. Overexpression of Hes1 and Hes5 in bone
marrow partly inhibits B-cell development [18]. Hes1
deficient mice are not viable and display multiple
developmental defects, reviewed in [7].
CD25 (IL2-R and preTa, pre-T-cell receptor alpha-
chain) were also shown to be Notch target genes in T-
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cells [19, 20]. In later stages of T-cell development, the
transcription factor GATA3, a master regulator for T-
cell development and later for Th1/2 lineage decision,
is a direct Notch target gene [21,22]. Flavell and
colleagues could show that Th2-mediated immunity
depends on either RBP-J or Notch [22] and that the
GATA3 promoter contains bona fide RBP-J binding
sites. In addition, the Pear lab demonstrated, that the
expression of dominant-negative mastermindlike-1
(dnMAML) results in impaired GATA3 transcription
levels and subsequently impaired IL4 production [21].
Two other Notch target genes, NRARP and Deltex-1
were shown to be potent negative regulators of Notch
signaling [23, 24].
Furthermore, Notch target genes implicated in cancer
are c-myc [16, 25, 26], cyclinD1 [27] and p21/Waf1
[28]. Other Notch target genes are NFkB2 [29], Ifi-
202, Ifi-204, Ifi-D3, and ADAM19 [19]. A number of
other genes have been reported including Notch1
itself and Notch3 [16], bcl-2 [30] and E2A [31] and
HoxA5, 9 and 10 [32].
What happens at Notch target genes in the absence of
activated Notch?
In the absence of Notch, RBP-J is retained at the gene
regulatory elements of Notch target genes (Fig. 1) and
acts there as a transcriptional repressor. Transcrip-
tional repression seems to be mediated by different
mechanisms. Based on biochemical experiments, it
was proposed that RBP-J can interact directly with
TFIID, a general transcription factor [33] or thatRBP-
J can recruit histone deacetylase-containing com-
plexes. Previously, at least three different interactions
betweenRBP-Jand corepressor complexes have been
described: a complex containing SMRT/mSin3A/
HDAC-1 (SMRT, Silencing Mediator for Retinoic
acid and Thyroid hormone receptor; HDAC-1, his-
tone deacetylase-1) or NCor/mSin3A/HDAC-1 com-
plex [34] and aCIR/SAP30/HDAC-2 complex [35]. So
far, the functional relevance of these biochemical
findings still remains to be seen.
We recently characterized anRBP-associated repress-
or complex composed of corepressorsRBP-J, SHARP
(SMRT and HDAC associated repressor protein),
CtBP (C-terminal binding protein) and CtIP (CtBP
interacting protein) [36]. The relevance of this finding
is supported by genetic data in Drosophila where
RBP-J homologue Su(H) can recruit the corepressor
dCtBP [37, 38]. Analogous to Drosophila dCtBP
mutants, CtBP knock-out mice reveal that this protein
plays a pivotal role in embryogenesis [39]. By now,
several other groups have shown that CtBP is found in
complex with histone demethylase LSD1/CoREST
[40] (see also below).
Epigenetic regulation of Notch target genes
Although precise mechanisms of epigenetic regula-
tion at Notch target genes are not completely under-
stood, cumulating evidence suggests that histone
modifications play a pivotal role in this process. The
presence of specific post-translational histone mod-
ifications define transcriptionally inactive or active
chromatin domains [41–44]. Acetylation and meth-
ylation represent the most common modifications of
the histone tails. This epigenetic, or non-DNA encod-
ed information, at promoters determines the outcome
of a transcriptional response in a specific cell type. The
precise mechanisms of epigenetic regulation of Notch
target genes are not yet known, although some
histone-modifying enzymes have been implicated in
the regulation of Notch target genes. The histone
acetyltransferase (HAT) p300 has been shown in
complex with RBP-J/Notch and is a positive cofactor
forNotch dependent transcription [45, 46]. Functional
interactions between Notch and PCAF and GCN5
have also been observed [47]. Furthermore, histone
deacetylases have been implicated in repression
mediated by the RBP-J/SHARP corepressor complex
[34, 48].
There is only very preliminary data available for
changes in histone methylation at Notch target genes.
So far, Bray and colleagues could demonstrate that
dynamic changes in histonemethylation ofH3K4occur
upon activation of Notch target genes [49]. Interest-
ingly, in Drosophila Bre1, the histone H2B ubiquitin
ligase, regulates not only activation of some Notch
target genes but also H3K4 methylation [50]. On the
otherhand, themammalianhistoneH3K4demethylase
LSD-1 has been implicated in Notch target gene
regulation [51]. The involvement of LSD-1 in the
regulation of Notch signaling is further supported by
genetic data in C. elegans [52]. Baumeister and collea-
gues used a suppressor screen of presenilin (C. elegans
sel-12), displaying an egg-laying defect and identified
members of the HDAC/CoREST/LSD1 complex as
genetic interactors. Interestingly, LSD-1 is also part of a
corepressor complex containingCtBP [40] which is one
component identified in the RBP-J corepressor com-
plex [36–38, 53]. Specificpolycombcomplexes, that are
known to methylate H3K27, have been proposed to
play a negative role in the regulation of Notch target
genes [54, 55]. In addition, polycomb component YY1,
which is itself a DNA binding protein, has been found
to be associated with NICD, to regulate c-myc pro-
moter activity [56]. Interestingly, overexpression of the
two polycomb epigenetic silencers, Pipsqueak and
Lola, enhance Notch-induced overproliferation and
causes hypermethylation at the Rb tumor suppressor
gene [57].
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Finally Bray and colleagues also reported that the
histone H3/H4 chaperone Asf1 contributes to repres-
sion of Notch target genes, as depletion of Asf1 by
RNAi caused derepression of some Notch target
genes and Asf and Notch interact genetically [58].
The RBP-J corepressor and coactivator complexes
RBP-J corepressor complex
RBP-J is the only transcription factor in the Notch
signaling cascade and is therefore a central player. In
the absence of Notch, RBP-J recruits a corepressor
complex that contains different components at differ-
ent Notch target genes. In the presence of NICD, the
corepressor complex is displaced and a coactivator
complex containing Notch and Mastermind is recruit-
ed (Fig. 1).
RBP-J itself. RBP-Jk [59] also called CBF1 or KBF2
[60] belongs to the CSL-protein family. CSL stands for
CBF1 (human), [61], Suppressor of Hairless (Droso-
phila), [62], Lag-1 (C. elegans), [63]. RBP-J (mouse)
[64], was first isolated from B-cells as a 60kDa DNA-
binding protein [59]. It is a highly conserved nuclear
protein with 75% sequence amino acid sequence
identity between human and Drosophila [62] that is
ubiquitously expressed. The DNA binding sequence
was identified as 5-CGTGGGAA-3 [64]. A paralo-
gue of RBP-J, RBP-L, was also described that is
almost exclusively expressed in the lung [65]. RBP-L
binds to DNA identical to RBP-J. Although RBP-L
did not interact with any Notch protein, it was shown
to cooperate with EBNA2 in transcriptional activa-
tion. RBP-L has been also found in complex with
PTF1, which has been proposed to play a role in
pancreas development [66]. The physiological role
and possible redundancy of the twoRBP factors is still
unknown.
The essential function of RBP-J has been demon-
strated by knock-out models in mice where the loss of
RBP-J expression exhibited an lethal phenotype in
embryonic development at day 10.5 of gestation.
Conditional deletion in the hematopoietic system
leads to a block in T-cell development and ectopic
development of B-cells in the thymus [68]. This
phenotype is very similar to Notch1 conditional
knock-out mice, indicating that “canonical” Notch
signaling (signaling through RBP-J) is the main
pathway in lymphoid development.
SKIP (Ski-interacting protein), originally identified
by the Hayward lab in a yeast-2-hybrid screen with
RBP-J, is evolutionary highly conserved [69]. When
part of the corepressor complex, SKIP can interact
with corepressor SMRT, thereby recruiting histone
deacetylases [34]. Hayward and colleagues have
presented data that demonstrates SKIP bridges inter-
actions between RBP-J and corepressors or RBP-J
and Notch [69,70]. This implies that SKIP is part of
both RBP transcriptional repression and activation
complexes. However chromatin immunoprecipitation
experiments from the Jones group suggest that SKIP is
only recruited to the promoter when Notch is present
[71].
CIR (CBF1 interacting corepressor) is, like SKIP, also
a direct RBP-J binding protein that binds also to
HDACs and SAP30 [35]. The function and in vivo
relevance of SKIP and CIR still remains to be
addressed. The role of histone deacetylases in the
RBP-J corepressor complex has been reported by
several groups [34,35,48,72]. HDAC1/2 are also part
of the LSD1/CoREST/CtBP complex [40].
KyoT2 is a LIM domain protein and interacts with
RBP-J through the binding motif on its C-terminus
generated by alternative splicing [73]. It has been
shown that KyoT2 can block Notch- or EBNA2
mediated transactivation. KyoT2 has also been
shown to recruit Polycomb group proteins HPC2
and Ring1 [54,74].
SHARP (SMRT and HDAC associated repressor
protein) was originally found in a yeast-2-hybrid
screen with SMRT (Silencing Mediator for Retinoid
and Thyroid hormone receptor) as a cofactor for
nuclear hormone receptors [75]. In our own experi-
ments, the corepressor protein SHARP was found to
interact directly with transcription factor RBP-J [48].
SHARP is a 400kDa nuclear protein that is ubiqui-
tously expressed. It is a member of the heterogeneous
SPEN-homology (Split-ends) domain family impli-
cated in biological processes from embryogenesis to
ageing. SHARP contains RRMs (RNA Recognition
Motifs) in the amino-terminal region and a highly
conserved SPOC-domain at the very C-terminus [76]
and reviewed in [77]; this domain has been crystallized
and contains a highly conserved positively charged
patch which is crucial for the interaction with cor-
epressors SMRT/NCoR[78,79]. The very last 34
amino acids of the SPOC-domain of SHARP are
required for binding to corepressors CtIP/CtBP [36]
and ETO (Eight-twenty-one) (Fig. 1) [78, 79]. In
addition, the SPOC-domain of SHARP can be
phosphorylated by Pak1 (p21-activated kinase-1),
and hence enhances SHARP corepressor function. It
also has been reported by the group of Han that the
SHARP C-terminal SPOC-domain can homodimer-
ize [80].
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The mouse homolog of SHARP, MINT (Msx-2-
Interacting Nuclear Target), was found in a screen
for interacting proteins of transcriptional repressor
Msx-2 (Muscle segment homeobox-2), [81]. MINT-
deficient mice are embryonic lethal, due to defective
heart, pancreas and hematopoietic development [82].
In fetal-liver transfer experiments, the Honjo group
could show that MINT-deficient splenic B cells differ-
entiated about three times more efficiently into
marginal zone B cells with a concomitant reduction
of follicular B cells. This is in agreement with the
finding that Notch directs differentiation into margin-
al zone B-cells. Conditional MINT knock-out mice
recapitulate the results from fetal liver transfer
experiments [83] and reveals negative regulation of
early thymocyte differentiation by Notch/RBP-J sig-
naling [84].
Our functional and biochemical findings as well as the
genetic data from Honjo and colleagues suggest that
SHARP might be the functional homolog of Droso-
philaHairless. In Drosophila melanogaster the Su(H)
interacting protein Hairless (H) is the major platform
for Su(H) dependent corepressor complex assembly.
It is important to note here, that so far Hairless
proteins cannot be identified within higher eukar-
yotes. For more detailed information, readers are
referred to a recent review [85].
Interestingly, there is a SHARP-like protein in mouse
and men, Rbm15/OTT1, that is implicated in acute
megakaryoblastic leukemia [86, 87] and has been
shown to interact with RBP-J, although the RBP-J
binding site of SHARP is not conserved in Rbm15/
OTT1 [88]. Rbm15/OTT1 deficient mice are charac-
terized by a loss of peripheral B-cells and an increase
in stem- myeloid- and megakaryocyte progenitors
[89].
Furthermore, the proteins SHARP, OTT1 and SKIP
were identified as spliceosomal components [90] and
therefore may also be implicated in post-transcrip-
tional processes [91].
SHARP as a “corepressor hub”: CtIP/CtBP, ETO and
SMRT
Several lines of evidence suggest that SHARP can be
involved in recruitment of different corepressor com-
plexes which demonstrates the versatility of Notch
regulated gene expression. It is intriguing that, CtIP,
ETO and SMRT bind to the same small region of the
large 400kDa protein SHARP.
In the absence of NICD, the RBP-J/SHARP hetero-
dimer recruits corepressors CtIP/CtBP to Notch
target genes [36], (Fig. 1A). As mentioned above,
this is particularly interesting because of the biochem-
ical and genetic interaction to histone demethylase
LSD-1, which was identified as a component of the
CtBP corepressor complex [40]. Furthermore, Dro-
sophila Hairless, the functional homolog of SHARP,
recruits corepressor dCtBP as well.
Moreover, we most recently demonstrated that ETO
is an additional component of the SHARP corepres-
sor complex [78], (Fig. 1B). Interestingly, leukemo-
genic fusion protein AML1/ETO can disturb the
normal, repressive function of ETO at Notch target
genes. This activating (or derepressing) effect of
AML1/ETOmay contribute to its oncogenic potential
in myeloid leukemia. Our data is supported by the
group of Pelicci who performed overexpression of
leukemogenic fusion protein AML1/ETO and ob-
served deregulation of some Notch target genes [92].
It still remains to be characterized in detail, which
corepressor is utilized at certain target genes in
specific cell types. Only in a few cases, like that of
SHARP, this was answered in part.
Coactivators of Notch
After engagement of the Notch receptor, proteolytic
cleavage events release the intracellular domain of
Notch (NICD), which then translocates into the
nucleus to displace RBP-J associated corepressors
and then recruits coactivators.
NICD itself. The best-described intracellular domain
of Notch1 contains five different segments: i) seven
tandem-ankyrin repeats, ii) the transactivation do-
main, iii) a glutamine-richOPAdomain, iv) a proline-,
glutamine-, serine- and threonine-rich PEST domain
and v) a RAM23 domain [93–95]. The RAM23
domain contains the nuclear localization signals
(NLSs) and is in combinationwith the ankyrin-repeats
responsible for the binding to RBP-J [94,96]. The
region between the ankyrin-repeats and the PEST
region is the transactivation domain (TAD) of NICD,
[97].Recently, three other functional regions ofNICD
have been identified, termed PPD (potential phos-
phorylated domain), DTS (downregulation targeting
sequence) and S4 (for WSSSSP). PPD is located
between the ankyrin repeats and PEST domain and
was shown to enhance the binding of NICD to RBP-J
[98]. DTS is required for endocytic trafficking of
Notch and crosstalk with the Ras signaling pathway
[99]. S4 is the C-terminal phosphorylation site,
important for Notch turnover (see below: CycC/
Cdk8 and phosphorylation of Notch receptor and
Fig. 1). NICD is the central player in the nucleus.
Unfortunately, many different laboratories use differ-
ent NICD constructs, either with the C-terminal OPA/
PEST or without, most of them from mice, but some
also human, making the interpretation of results of
different groups difficult to compare. The Notch
modifications (glycosylation, phosphorylation, ubiq-
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uitinylation), proteolytic cleavage events as well as
mutations associated with leukemia development
have been extensively reviewed elsewhere and are
beyond the scope of this review [4, 100].
Mastermind/p300. Mastermind is a member of the
Mastermind-like (MAML) family of coactivators
[101, 102], originally identified in genetic screens in
Drosophila [2]. Recently, the first detailed view of the
coactivator complex was provided by the determina-
tion of the structure of full-length RBP-J bound to
Figure 1.Molecular steps involved in Notch signaling. Notch ligands and Notch receptors represent proteins with a single transmembrane
spanning domain. During protein maturation, the precursor of the Notch receptor is cleaved by a furin-like convertase in the trans Golgi
network and the resulting fragments are transported to the cell surface as a non-covalently linked heterodimeric receptor molecule (not
shown). I. Repression of Notch target genes. In the absence of activated Notch signaling, the DNA-binding protein RBP-J recruits
corepressor complexes to represses transcription of Notch target genes. Two pivotal corepressor complexes are shown where RBP-J
interacts with the central corepressor protein SHARP (A and B). In these complexes SHARP serves as a protein interaction platform
recruiting CtIP/CtBP (A) or ETO (B) together with additional corepressors and histonemodifying enzymes. II. Activation of Notch target
genes. Upon Notch ligand binding an ADAM-type metalloprotease catalyzes a specific cleavage step (S2) at the Notch receptor.
Subsequently, a further cleavage step (S3) catalyzed by a g-secretase containing complex, releases the intracellular domain of Notch
(NICD) thatmigrates to the nucleus. NICD interacts withRBP-Jand recruits a coactivator complex composed ofMastermind (MAML-1)
and other chromatin modifying transcription factors resulting in the transcriptional activation of Notch target genes.
III. NICD degradation and turnover of the coactivator complex.NICD phosphorylation facilitated by the mediator components CyclinC/
Cdk8 and ubiquitinylation via the E3 ubiquitin ligase Fbw7/Sel10 results in rapid NICD degradation and turnover of the coactivator
complex. Subsequently, newly establishedRBP-Jassociated corepressor complexes shut-down transcription ofNotch target genes. Further
information is given in the text.
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DNA in combination with a truncated form of NICD
and the interacting part ofMAML [103] and reviewed
in [104, 105]. In Drosophila, the mastermind gene
codes for a glutamine-rich protein, indicative for an
transcriptional activators. Mammalian MAML was
shown to stabilize the RBP/NICD bound to DNA
during activation of target genes [102]. In vivo, the
importance of MAML has been impressively demon-
strated with dominant-negative MAML, which com-
pletely blocks all Notch-mediated transcriptional
activation [106]. This tool has been exploited to
study the physiological role of “canonical” (RBP-J
dependent) Notch signaling in detail, reviewed in
[107].
The ternary complex of RBP-J/NICD/MAML re-
cruits histone acetyltransferase p300 to activate Notch
target genes [45, 46, 108]. The Capobianco lab set out
to purify the endogenous Notch-coactivator complex
[109]. Using nuclear extracts from a T-cell leukemia
line (SupT1), they could demonstrate in gel filtration
experiments that this complex peaks at 1–1.5MDa in
size. The identity of further components still remains
unresolved.
Structure of the RBP-J/NICD/MAML coactivator
complex
The first detailed view of the transcription factor
RBP-J (CSL) was provided by the determination of
the structure of the C. elegans ortholog, Lag-1, bound
to cognate DNA [110]. The structure revealed that
RBP-J is composed of three domains: N-terminal
(NTD), beta-trefoil (BTD) and C-terminal (CTD).
The N- and C-terminal domains share structural
similarities with the Rel-homology domain similar to
those ofNF-kBandNFATproteins, reviewed in [104].
Previous biochemical and cellular studies demonstrat-
ed that bothNICDand corepressors interact primarily
with CSL through a central region corresponding to
the beta-trefoil domain, reviewed in [104]. NICD
primarily interacts strongly through its RAM-domain,
but only weakly through its ankyrin repeats [94].
However, the ankyrin repeats are needed for the
formation of the RBP-J/NICD/MAML ternary com-
plex and transcriptional activation [10].
Several structures have been determined for the
ankyrin repeats of NICD, including orthologs of
mammals, D. melanogaster and C. elegans, reviewed
in [104]. The ankyrin repeat fold is a common protein-
protein interaction motif and is composed of multiple
repeats that form an elongated molecule; Each repeat
contains two alpha helices connected by a turn and a
beta-hairpin motif. Recently two ternary complex
structures of RBP-J/NICD/MAML bound to DNA
were determined for C. elegans [111] and human
orthologous proteins [103]. The ternary complex
reveals that Mastermind adopts a strikingly bent
helical conformation, forming a tripartite structure
with ankyrin repeats 3–7 of NICD and the C-terminal
domain of RBP-J (Fig. 2). The crystal structures
illuminate some of the molecular details fundamental
to RBP-J and NICD. One should keep in mind that
apart from RBP-J, only relatively small fragments of
NICD and MAML were resolved. Understanding the
complete coactivator complex, both functionally and
structurally, remains a tremendous task for the future.
Negative regulators of activated Notch signaling
NRARP and Deltex proteins are both important
negative feedback regulators of Notch receptor medi-
ated signaling. NRARP was first discovered in
Xenopus and is a small 114 a.a. ankyrin-repeat
containing protein [24]. NRARP is not only a direct
Notch target gene [112] but interacts physically with
NICD and blocks Notch-mediated transactivation
and T lineage commitment [113, 114]. A similar
observation was described for Deltex-1 [115]. En-
forced expression of Deltex-1 in hematopoietic pro-
genitor cells results in B-cell development at the
expense of T-cell development [23]. However, in loss
of function experiments, T-cells that lackDeltex-1 and
Deltex-2 develop normally [116]. This means that
endogenous levels of Deltex-1 and Deltex-2 are not
important for regulating Notch signals.
CyclinC/Cdk8 and phosphorylation of Notch receptor
The Jones group has shown that Mastermind recruits
CyclinC/Cdk8, which is part of the repressive Medi-
ator complex [71]. This Cyclin/Cdk pair strongly
enhances NICD phosphorylation and PEST-depend-
ent degradation after ubiquitinylation by the Fbw7/
Sel10 ubiquitin ligase (Fig. 1). The authors conclude
that CyclinC/Cdk8 is important for Notch activation
and turnover. The importance of Cdk8 as Notch
kinase is challenged by the group of J. Aster; in this
study a dominant-negative Cdk8 fails to affect the
difference inNICDwild type andNICDmutated at all
putative Cdk8 phosphorylation sites [117]. Thus, the
role of CyclinC/Cdk8, and therefore of Mediator,
remains controversial so far.
Notch signaling in development and differentiation
Notch signaling is activated upon cell-to-cell contact
as a result of interactions between Notch receptors
and their ligands Delta or Jagged. Signaling mediated
by Notch receptors and ligands is involved in regu-
lation of many biological functions, such as apoptosis,
cell proliferation, differentiation and lineage deci-
sions during embryonic development, and homeo-
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stasis of adult self-renewing organs, reviewed in [2, 4].
In Figure 3, we summarize the different mechanisms
of how Notch influences these key developmental
decisions. Lateral inhibition (Fig. 3A) occurs during
neurogenesis where a group of equipotent cells
expressing equal amounts of Notch receptor and
ligand begin to gradually express either Notch recep-
tor or Notch ligand. In the case of lateral induction
(Fig. 3B), the Notch ligand is provided by a different
cell in close proximity. Awell-studied example for this
is lymphopoiesis where a common lymphoid progen-
itor develops into a pre-T cell, in case a thymic stromal
cell provides the inductive signal. In the absence of the
inductive signal, i. e., in the bone-marrow environ-
ment, the common lymphoid progenitor differentiates
into a B-cell with the help of bone marrow stromal
cells. Notch can alsomaintain stem cell state and act as
a gatekeeper (Fig. 3C). An example for this is the
intestine where Notch prevents the crypt progenitor
cells (TA) from differentiating. On the other hand,
Notch signaling can also drive a terminal differentia-
tion program (Fig. 3D) by inducing cell cycle arrest
like it is observed in keratinocytes in the skin.
Notch regulates binary cell fate decisions and stem cell
maintenance
Notch signaling has been extensively studied first in
Drosophila. The classical example is that Notch
signaling restricts cell fates in the neural-epidermal
choice. Special groups of cells known as proneural
clusters have neuronal potential because of their
expression of proneural helix-loop-helix transcrip-
tional regulators. Notch signaling restricts neural
differentiation by repressing the expression of pro-
neural genes [118]. Failure to activate Notch signaling
leads to formation of more neuronal clusters because
of enhanced expression of proneural genes; constitu-
tive activation of Notch signaling leads to the contrary
and suppresses neural differentiation, reviewed in [2,
4] (Fig. 3A). Many proteins that mediate neuronal
repression inDrosophila are encoded by the Enhanc-
er of Split complex, reviewed in [7, 119]. Therefore,
Notch signaling seems to be an evolutionary con-
served pathway for preventing equipotent cells from
acquiring the same fate.
In vertebrates, Notch signaling also represses neuro-
genesis (andmyogenesis) via helix-loop-helix repress-
ors called Hairy/Enhancer of split, or Hes, transcrip-
tional repressors mentioned above. Taylor and col-
leagues could demonstrate that conditional ablation
of Notch1 in mice leads to premature onset of
neurogenesis [120]. Subsequently, they could show
that Notch1 signaling is required for both neuron and
glia formation. Using transgenic Hes5 promoter
coupled to a GFP-reporter, two groups could show
that the GFP expressing cells have self-renewal
capability and multipotency in transplantation assays
[121, 122].
An example of Notch signaling in vertebrates in-
volved in stem cell maintenance is the intestinal crypt
compartment in the gut, a highly proliferative tissue,
reviewed in [123]. Post-natal gut specific inactivation
of RBP-J results in the complete loss of proliferating
transient amplifying (TA) cells [124]. In a reciprocal
experiment, expression of activated Notch1 (NICD)
in the gut inhibits differentiation of crypt progenitors
[125]. These genetic experiments establish Notch
signaling as a gatekeeper for intestinal crypt cells in
mice. In pharmacological experiments using g-secre-
Figure 2. Stereo-view of the
DNA/RBP-J/Notch/MAML co-
activator complex. RBP-J (also
called CSL) colored in blue binds
to a DNA oligonucleotide (red
and yellow). The ankyrin repeats
(ANK) of Notch intracellular
domain (NICD) are displayed in
purple. A polypeptide of Master-
mind (MAML), displayed in or-
ange, is sandwiched between the
RBP-J and NICD. Stereo-view
was established with the 2F8X
dataset (103) using the PyMOL
software.
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tase inhibitor (GSI), which inhibits cleavage of Notch,
transient amplifying cells are lost [126].
Notch induces terminal differentiation
A second general role of Notch is to promote the
development of a given cell type or body region, often
by inducing the expression of positively acting regu-
latory molecules. For example, in Drosophila wing
development, Notch signaling specifies the wing
margin, a line of cells that organizes the outgrowth
of thewing by activation of the gene vestigal, reviewed
in [119]. In mammals, Notch signaling initiates a
terminal differentiation program in human skin [127,
128]. In mouse keratinocytes, Notch signaling stim-
ulates expression of early differentiation markers and
enhances the expression of cell cycle regulator p21/
Waf1, causing cell-cycle arrest of basal cells and thus
allowing onset of differentiation [28] (Fig. 3D).
Notch in hematopoiesis
Fetal/adult stem cells
In development, Notch is essential for the emergence
of definitive hematopoietic stem cells during fetal life
[129]. During the onset of definitive hematopoiesis in
the embryo, Notch1/RBP-J dependent signaling leads
to the activation of GATA-2 [130], which has been
shown to be an essential transcription factor for
hematopoiesis [131]. Whether Notch signaling is
similarly important for adult hematopoiesis remains
controversial: Several studies using overexpression of
activated form of Notch1 in primary cells as well as
stimulation of hematopoietic stem cells with Notch
ligand suggest that Notch inhibits differentiation
leading to increased self-renewal, reviewed in [132].
In addition, Reya and colleagues used a transgenic
Notch reporter mouse, with RBP-J responsive ele-
ments driving a GFP reporter, and could show that
Notch signaling is active inGFP+ adult hematopoietic
stem cells (HSCs) and is reduced in differentiated cells
[133]. Inhibition of Notch leads to accelerated differ-
entiation of HSCs in vitro and depletion of HSCs in
vivo. On the other hand, none of the loss-of-function
studies have demonstrated a role for theNotch/RBP-J
signaling pathway in hematopoietic stem cell main-
tenance. Neither inducible knock-out of RBP-J [68],
Notch1 [134] or Jagged1 [135] have led to a reduction
of hematopoietic stem cells. In addition, Pear and
colleagues showed that HSCs that carry dominant-
negative mastermind (dnMAML) can engraft nor-
mally in bone-marrow transplantation assays, and that
normal frequencies in long-term reconstitution assays
are achieved in both the presence or absence of
dnMAML [136].
T-cell development
The best-studied example in mammals is how Notch
signaling determines a hematopoietic progenitor cell
to differentiate into a T-lymphocyte (Fig. 3B). The
importance of Notch signaling for the induction of T-
cell fate was first demonstrated in mice in which the
Notch1 gene was conditionally deleted using Mx-Cre.
These mice exhibited a complete block in T-cell
development at an early stage of differentiation and
an emergence of ectopic B-cell development in the
thymus [134]. Conversely, overexpression of constit-
utive-active Notch (NICD) in the bone marrow
instructed a T-cell fate in bone marrow progenitors
and inhibited B-cell development [137]. The same
effect was observed after overexpression of Delta4 in
the thymus [138]. Ex vivo, this phenomenon has been
exploited using bone marrow stromal cell lines
expressing Notch ligandDelta-like1. T-cell precursors
can be efficiently generated by co-culturing hemato-
Figure 3. Notch functions in development and differentiation.
Notch signaling has different effects in different organs and tissues.
A and B: Notch in binary cell-fate decisions. A: Within a group of
cells of the same type which express equal amounts of ligands and
Notch receptors (left) a single cell starts to differentiate e.g., into a
neuronal precursor cell with increased surface expression of ligand
(right). The ligand activates the Notch signaling cascade in the
neighboring cells, thereby inhibiting differentiation into neuronal
precursor cells. B: A precursor cell (e.g., early lymphoid precursor
cell) is instructed to adopt fate A (e.g., B cell) in the absence of a
Notch ligand (upper) from a different cell type (e.g., stromal cell).
In the presence of Notch ligand, the Notch pathway is activated
(lower) to instruct the precursor cell to adopt fateB (e.g., T cell). C:
A particular cell type induces Notch signaling in stem cells to
maintain an undifferentiated state (e.g., stem cells within the
intestinal crypts). D: Ligand expression in a precursor cell can
activate the Notch pathway to initiate terminal differentiation and
cell cycle arrest in descendant cells (e.g., keratinocytes in the skin).
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poietic progenitors on these stromal Notch-ligand
expressing cells [139].
Notch signaling also potentially plays a role in the
development of gamma/delta T-cells and natural killer
cell development, reviewed in [107, 140]. Recent data
also indicate that Notch signaling can direct the
differentiation and activity of peripheral T-cells,
reviewed in [107, 141]. During helper T-cell differ-
entiation, Notch is involved in generating optimal Th2
cell responses by upregulating GATA3 and thereby
promoting IL-4 expression [21, 22].
Notch and B-cell development
In addition to its well-established function in T-cell
development, Notch signaling is important for later
stages in B-cell development. Early stages of B-cell
development do not depend on Notch signaling
components and the B-cell master regulator Pax-5
even suppresses Notch1 expression, reviewed in [142].
Although Notch1 is the key Notch receptor during T-
cell development, Notch-2 is the crucial receptor to
fulfill functions in B-cells. Notch-2 is essential for the
development of splenic marginal zone B-cell whereas
it is dispensable for follicular B-cell [143]. This
decision depends on Notch-2, its ligand Delta-1 as
well as on RBP-J, reviewed in [140]. Recently, it was
also shown that Notch signaling plays an important
role in the terminal differentiation of mature B-cells
into antibody-secreting cells [144] and that Notch
activity can synergize with the B-cell receptor and
CD40 signaling to enhance B-cell activation [145].
Notch in myeloid/erythroid differentiation
It has been shown that Notch1/RBP-J positively
regulates apoptosis during erythroid development
[146]. However, its role in myelopoiesis remains
unclear and controversial. On the one hand, some in
vitro studies show that activated Notch signaling
inhibits differentiation of myeloid precursors [147–
149]. This is also supported by a recent work using a
conditionally induced null mutation in the FX locus,
that results in a myeloproliferative phenotype [150].
FX encodes an essential enzyme in the GDP-fucose
synthesis pathway. In addition, FX is essential for the
fucosylation of the EGF repeats of Notch, a crucial
post-translational modification for proper Notch
function [4]. On the other hand the group of Just has
shown that a conditionally NICD, fused to the ligand
binding domain of estrogen receptor promotes mye-
loid differentiation [151]. In loss-of-function studies,
Radtke and colleagues could show that in conditional
Notch1 deficient mice development of granulocytes,
macrophages and dendritic cells is normal [152]. The
same holds true for conditional RBP-J deficient mice
[68]. In addition, in mice reconstituted with stem cells
carrying a dominant negative form of Mastermind
(dnMAML, see above), development of myeloid
compartment is also not affected [136].
For further detailed information, readers are referred
to several excellent in-depth reviews on the topic of
Notch signaling in hematopoiesis, especially lympho-
poiesis [107, 140, 153, 154].
Notch signaling in cancer
There is increasing evidence that Notch signals are
oncogenic in many cellular contexts, for example in T-
cell leukemia (T-ALL), breast and colon cancer,
reviewed in [123, 155]. Notch-4 was first identified
as a proviral integration sites, named int-3, in retro-
virus-inducedmurine mammary cancer [156]. Wheth-
er Notch4 plays a genuine role in normal mammary
development remains unclear so far.
Notch and leukemia
The definite example of oncogenic Notch signaling is
found in T-acute lymphoblastic leukemia (T-ALL), an
aggressive neoplasm of immature T-cells. Human
Notch was originally identified at a chromosomal
breakpoint of a subset of T-ALLs containing a t(7;9)
chromosomal translocation. These leukemic cells
express a truncated Notch1 allele (TAN1), that
encodes a constitutive-active Notch1 polypeptide
[157] reviewed in [100] and [123]. In support of this,
many studies in mice have subsequently revealed that
expression of constitutive-active Notch proteins leads
to potent and specific induction of T-ALL [158]. Aster
and colleagues searched for specific Notch1mutations
in T-ALLs that do not harbor the t(7;9) translocation
and identified two hotspot regions in theNotch1 gene:
the heterodimerization and the PEST-domain [159].
Mutations in the heterodimerization domain enhance
S3 cleavage of Notch and cause, via augmented NICD
production, a significant increase in Notch signaling.
Genetic and biochemical data suggest that loss of the
PEST-domain enhance NICD protein stability, re-
viewed in [160]. Synergistic heterodimerization and
PEST domainmutants are found together in cis in 10–
20% of human T-ALLs [159] and low copy number
amplification of Notch1 has also been reported [161].
Notch mutations appear to collaborate with a diverse
collection of other proteins dysregulated in T-ALL.
Retroviral oncogenesis in mice indicates a synergistic
interaction between Notch1 and c-myc [162], E2A/
pbx [163] and dominant negative forms of Ikaros [164]
to enhance development of T-ALL.
Apart from Notch1, Notch3 was consistently ex-
pressed in human T-ALL and dramatically reduced
in clinical remission [165]. It was shown by the
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Screpanti group that Notch target genes Hes1 and
preTa are associated with Notch3 expression. Ex-
pression of these genes is restricted to thymocytes and
usually not seen in normal mature peripheral T-cells.
Thus, the expression of Hes1, Notch3 and preTa
characterizes the active and relapsing face of T-ALL,
reviewed in [123].
Notch target genes and herpes viruses (Epstein-Barr
and Kaposis sarcoma-associated herpes viruses)
The Epstein-Barr virus nuclear antigen 2 (EBNA2)
and NICD have been shown to be partially inter-
changeable, reviewed in [166]. Therefore EBNA2 has
been proposed to be the functional homolog of NICD.
EBNA2 is a transcriptional transactivator that is one
of the first viral genes expressed after EBV infection
of B-cells and is essential for Epstein-Barr virus
(EBV) immortalization of B-cells in vitro [167, 168].
EBNA2, like NICD, does not bind to DNA directly,
but needs the transcription factor RBP-J [169, 170].
Recombinant viruses carrying an EBNA2 gene that
lacks theRBP-J interaction domain are no longer able
to immortalize B-cells [171]. EBNA2 and NICD are
found to regulate the same cellular and viral promot-
ers and both have been shown to be partially
interchangeable in regard to activation of target
genes in B-cell lines andmodulation of differentiation
processes, reviewed in [166].
In addition to EBV, the lytic switch protein RTA of
Kaposis sarcoma-associated herpes virus (KSHV)
has been found to bind to RBP-J [172], reviewed in
[173]. KSHV establishes latency in B-cells, like EBV,
but can also infect endothelial cells. Other viruses that
have interactions with the Notch pathway are adeno-
virus, HPV and simian virus 40 (SV40), reviewed
[173]. The first association of adenovirus came from
the recognition of a RBP-J binding site in the pIX
promoter [5]. Subsequently, adenovirus 13SE1A was
shown to bind toRBP-Jand to be capable of activating
promoters containing RBP-J binding sites [174].
Therefore, EBV, KSHV, HPV, SV40 and adenovirus
encode proteins that bind to RBP-Jand mimic certain
aspects of Notch signaling. In this way the virus can
manipulate the ability of the Notch signaling pathway
to influence proliferation and differentiation process-
es.
Future perspectives
Understanding how different Notch target genes are
activated or repressed in different cell types still
remains enigmatic. In our view, the key for under-
standing this problem is the composition of the RBP-J
associated corepressor and coactivator complexes and
the epigenetic status of the relevantNotch target gene.
Switch-on and switch-off systems for Notch signaling
are now needed to analyze the dynamic molecular
mechanism(s) of transcriptional regulation.
Histone modifying enzymes, such as histone acetyl-
transferases and deacetylases (HDACs) as well as
histone methylases and demethylases, have great
potential in being drug targets; HDAC inhibitors are
already used in clinical trials. Therefore, understand-
ing the epigenetic regulatory mechanism controlling
key Notch target genes could be translated into new
therapeutic approaches, for example, in regard to
leukemia.
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